Cannabis stocks in focus as Tilray beats on Q1 revenue and lifts outlook
Source: SeekingAlpha
2025-10-09 07:54:29 ET
More on Tilray
- Tilray: Another Unjustified Rally
- Sell Tilray Brands Before Q1 Financials Report
- Tilray Brands: Momentum Now, Fundamentals Later
- Tilray Brands Q1 Earnings Preview: What to expect
- Earnings week ahead: PEP, DAL, TLRY, STZ, MKC, and more
Read the full article on Seeking Alpha
For further details see:
Cannabis stocks in focus as Tilray beats on Q1 revenue and lifts outlook
AdvisorShares Pure US Cannabis ETF
NASDAQ: MSOS
MSOS Trading
3.99% G/L:
$5.0072 Last:
4,246,867 Volume:
$4.765 Open:
MSOS Latest News
April 24, 2026 11:41:23 am
Trump Just Eased Federal Marijuana Laws. Is there an Investment Case for Cannabis ETFs Right Now?
April 23, 2026 09:24:00 am
AdvisorShares Issues Statement on Finalization of Federal Cannabis Rescheduling
February 23, 2026 12:29:41 pm
Quantum Computing Inc. Positions Itself Between Quantum Hardware and Enterprise Adoption as Anson Funds Exits
February 17, 2026 08:15:00 pm
If Pot Stocks Rebound in 2026, These Are the 3 Best Cannabis Companies to Own
